Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C.
Previous studies have shown that catecholamine secretion from the adrenal medulla plays a critical role in chronic intermittent hypoxia (CIH)-induced alterations in cardiovascular function. In the present study we examined the cellular mechanisms associated with the effects of CIH on adrenal chromaffin cell catecholamine secretion. Experiments were performed on adult male mice (C57/BL6) that were exposed to 1-4 days of CIH or to normoxia. Perforated patch electrical capacitance recordings were performed on freshly prepared adrenal medullary slices that permit separating the chromaffin cell secretion from sympathetic input. CIH resulted in a significant increase in the readily releasable pool (RRP) of secretory granules, and decreased stimulus-evoked Ca(2+) influx. Continuous hypoxia (CH) either for 2.5 h (equivalent to hypoxic duration accumulated over 4 days of CIH) or for 4 days were ineffective in evoking changes in the RRP and Ca(2+) influx. CIH activated PKC in adrenal medullae as evidenced by increased phosphorylation of PKC at Thr(514) and PKC inhibitors prevented CIH-induced increases in the RRP and restored stimulus-evoked attenuation of Ca(2+) influx. CIH resulted in elevated thio-barbituric acid reactive substances (TBARSs, an index of oxidized proteins) and an antioxidant prevented CIH-induced changes in the RRP, suggesting the involvement of reactive oxygen species (ROS). These results demonstrate that CIH increases the RRP in adrenal chromaffin cells via ROS-mediated activation of PKC and suggest that CIH can directly affect the secretory capacity of chromaffin cells and contribute, in part, to elevated catecholamine levels.
Kuri
Barbara A
BA
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106-4970, USA.
Khan
Shakil A
SA
Chan
Shyue-An
SA
Prabhakar
Nanduri R
NR
Smith
Corey B
CB
D000313:Adrenal Medulla / Q000201:enzymology / Q000378:metabolism*; D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D019439:Chromaffin Cells / Q000201:enzymology / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011493:Protein Kinase C / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism; D022142:Secretory Vesicles / Q000378:metabolism*; D013997:Time Factors
D002395:Catecholamines; D017382:Reactive Oxygen Species; D011493:Protein Kinase C
Respir Physiol. 2000 Feb;119(2-3):181-7
10722861
J Physiol. 2006 Aug 15;575(Pt 1):229-39
16777938
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17060-5
12446844
J Clin Invest. 2003 Apr;111(7):1057-64
12671055
J Appl Physiol (1985). 2003 Jun;94(6):2342-9
12533494
J Physiol. 2003 Dec 15;553(Pt 3):707-17
14500763
Pflugers Arch. 1993 Jul;424(2):105-12
8414901
Science. 1993 Nov 12;262(5136):1061-5
8235626
FEBS Lett. 1995 Feb 13;359(2-3):137-41
7867786
Neuron. 1996 Jun;16(6):1209-20
8663997
Curr Biol. 1995 Dec 1;5(12):1394-1403
8749392
J Appl Physiol (1985). 1997 Jul;83(1):95-101
9216950
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11233-7
9326592
Respiration. 1997;64 Suppl 1:22-8
9380957
Neuron. 1998 Jun;20(6):1243-53
9655511
J Neurosci. 1999 Jan 15;19(2):589-98
9880579
Neuron. 1999 Jul;23(3):607-15
10433271
Hypertension. 1999 Aug;34(2):309-14
10454459
J Neurochem. 2005 Apr;93(1):47-52
15773904
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):447-9
15854156
J Neurophysiol. 2005 Aug;94(2):1037-47
15800072
Biochem Biophys Res Commun. 2000 Jul 14;273(3):960-6
10891355